Literature DB >> 17086052

AIDS vaccine development and challenge viruses: getting real.

Josef Vlasak1, Ruth M Ruprecht.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17086052     DOI： 10.1097/QAD.0b013e328010beb5

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  15 in total

1.  Adaptation of an R5 Simian-Human Immunodeficiency Virus Encoding an HIV Clade A Envelope with or without Ablation of Adaptive Host Immunity: Differential Selection of Viral Mutants.

Authors:  Mingkui Zhou; Michael Humbert; Muhammad M Mukhtar; Hanna B Scinto; Hemant K Vyas; Samir K Lakhashe; Siddappa N Byrareddy; Gregor Maurer; Swati Thorat; Joshua Owuor; Zhao Lai; Yidong Chen; Anthony Griffiths; Agnès-Laurence Chenine; Sanjeev Gumber; François Villinger; David Montefiori; Ruth M Ruprecht
Journal:  J Virol       Date:  2019-04-17       Impact factor: 5.103

Review 2.  No acquisition: a new ambition for HIV vaccine development?

Authors:  Samir K Lakhashe; Guido Silvestri; Ruth M Ruprecht
Journal:  Curr Opin Virol       Date:  2011-10       Impact factor: 7.090

3.  Discovery and biological characterization of two novel pig-tailed macaque homologs of HHV-6 and HHV-7.

Authors:  Jeannette P Staheli; Michael R Dyen; Patrick Lewis; Serge Barcy
Journal:  Virology       Date:  2014-10-31       Impact factor: 3.616

4.  Bimodal AIDS vaccine approach: induction of cellular as well as humoral immunity can protect from systemic infection.

Authors:  Robert A Rasmussen; Samir K Lakhashe; Ruth M Ruprecht
Journal:  Vaccine       Date:  2010-05-26       Impact factor: 3.641

5.  AIDS and optic neuritis in a rhesus monkey infected with the R5 clade C SHIV-1157ipd3N4.

Authors:  Anapatricia García; Nagadenahalli B Siddappa; Qingsheng Li; Ashley T Haase; Katherine Paul; Fawn Stroud; Xiaodong Zhang; Jack A Fountain; François Villinger; Francis J Novembre; James G Else; W Evan Secor; Ruth M Ruprecht
Journal:  J Med Primatol       Date:  2010-10       Impact factor: 0.667

6.  A comparative study of HIV-1 clade C env evolution in a Zambian infant with an infected rhesus macaque during disease progression.

Authors:  For Yue Tso; Federico G Hoffmann; Damien C Tully; Philippe Lemey; Robert A Rasmussen; Hong Zhang; Ruth M Ruprecht; Charles Wood
Journal:  AIDS       Date:  2009-09-10       Impact factor: 4.177

7.  Differential pathogenicity of SHIV infection in pig-tailed and rhesus macaques.

Authors:  Patricia Polacino; Kay Larsen; Lindsey Galmin; John Suschak; Zane Kraft; Leonidas Stamatatos; David Anderson; Susan W Barnett; Ranajit Pal; Kristen Bost; A H Bandivdekar; Christopher J Miller; Shiu-Lok Hu
Journal:  J Med Primatol       Date:  2008-12       Impact factor: 0.667

8.  R5 clade C SHIV strains with tier 1 or 2 neutralization sensitivity: tools to dissect env evolution and to develop AIDS vaccines in primate models.

Authors:  Nagadenahalli B Siddappa; Jennifer D Watkins; Klemens J Wassermann; Ruijiang Song; Wendy Wang; Victor G Kramer; Samir Lakhashe; Michael Santosuosso; Mark C Poznansky; Francis J Novembre; François Villinger; James G Else; David C Montefiori; Robert A Rasmussen; Ruth M Ruprecht
Journal:  PLoS One       Date:  2010-07-21       Impact factor: 3.240

9.  Neutralization-sensitive R5-tropic simian-human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infection.

Authors:  Nagadenahalli B Siddappa; Ruijiang Song; Victor G Kramer; Agnès-Laurence Chenine; Vijayakumar Velu; Helena Ong; Robert A Rasmussen; Ricky D Grisson; Charles Wood; Hong Zhang; Chipeppo Kankasa; Rama Rao Amara; James G Else; Francis J Novembre; David C Montefiori; Ruth M Ruprecht
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

10.  Live-virus exposure of vaccine-protected macaques alters the anti-HIV-1 antibody repertoire in the absence of viremia.

Authors:  Barbara C Bachler; Michael Humbert; Samir K Lakhashe; Robert A Rasmussen; Ruth M Ruprecht
Journal:  Retrovirology       Date:  2013-06-21       Impact factor: 4.602
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.